Latest Articles
ESGN Targets Early Diagnosis With Nationwide Endometriosis Essay Competition - Leadership News
ESGN Targets Early Diagnosis With Nationwide Endometriosis Essay Competition Leadership News
Published: Feb. 25, 2025, 4:43 p.m.
Karyopharm targets $1B revenue potential for Selinexor in myelofibrosis amid Phase 3 progress - MSN
Karyopharm targets $1B revenue potential for Selinexor in myelofibrosis amid Phase 3 progress MSN
Published: Feb. 21, 2025, 12:07 p.m.
Study reveals potential therapeutic target for endometriosis - MSN
Study reveals potential therapeutic target for endometriosis MSN
Published: Feb. 12, 2025, 5:16 p.m.
Study reveals potential therapeutic target for endometriosis - Medical Xpress
Study reveals potential therapeutic target for endometriosis Medical Xpress
Published: Feb. 12, 2025, 3:26 p.m.
Targeting PAK5 could offer new therapeutic approach for endometriosis - News-Medical.Net
Targeting PAK5 could offer new therapeutic approach for endometriosis News-Medical.Net
Published: Feb. 12, 2025, 2:38 a.m.
Targeting the splicing factor SNRPB inhibits endometrial cancer progression by retaining the POLD1 intron - Nature.com
Targeting the splicing factor SNRPB inhibits endometrial cancer progression by retaining the POLD1 intron Nature.com
Published: Feb. 5, 2025, 11:37 a.m.
The Elon Musk effect is in full swing / shein targeted by a CE / Outbrain investigation, now call me a tank! - Businesslife.co
The Elon Musk effect is in full swing / shein targeted by a CE / Outbrain investigation, now call me a tank! Businesslife.co
Published: Feb. 4, 2025, 10:35 p.m.
Endometriosis affects 1m+ in Australia. This AI platform is targeting women’s health - Forbes Australia
Endometriosis affects 1m+ in Australia. This AI platform is targeting women’s health Forbes Australia
Published: Feb. 4, 2025, 8:24 a.m.
Endometriosis affects 1m+ Australians. Now there’s an AI platform targeting women’s health - Forbes Australia
Endometriosis affects 1m+ Australians. Now there’s an AI platform targeting women’s health Forbes Australia
Published: Feb. 4, 2025, 8:24 a.m.
Engineered Exosomes Restore miR-508-5p Expression in Uterine Corpus Endometrial Carcinoma and Reduce Tumor Progression and Metastasis by Targeting DLL3 - Frontiers
Engineered Exosomes Restore miR-508-5p Expression in Uterine Corpus Endometrial Carcinoma and Reduce Tumor Progression and Metastasis by Targeting DLL3 Frontiers
Published: Feb. 3, 2025, 2:27 p.m.
Link copied to clipboard!